About iradimed corp - IRMD
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Orlando, FL.
IRMD At a Glance
IRadimed Corp.
12705 Ingenuity Drive
Orlando, Florida 32826
| Phone | 1-407-677-8022 | Revenue | 83.81M | |
| Industry | Medical Specialties | Net Income | 22.48M | |
| Sector | Health Technology | 2025 Sales Growth | 14.434% | |
| Fiscal Year-end | 12 / 2026 | Employees | 166 | |
| View SEC Filings |
IRMD Valuation
| P/E Current | 54.64 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 55.624 |
| Price to Sales Ratio | 14.919 |
| Price to Book Ratio | 13.141 |
| Price to Cash Flow Ratio | 50.12 |
| Enterprise Value to EBITDA | 43.909 |
| Enterprise Value to Sales | 14.309 |
| Total Debt to Enterprise Value | N/A |
IRMD Efficiency
| Revenue/Employee | 504,903.614 |
| Income Per Employee | 135,421.687 |
| Receivables Turnover | 6.133 |
| Total Asset Turnover | 0.809 |
IRMD Liquidity
| Current Ratio | 7.977 |
| Quick Ratio | 6.835 |
| Cash Ratio | 5.025 |
IRMD Profitability
| Gross Margin | 76.746 |
| Operating Margin | 31.196 |
| Pretax Margin | 33.838 |
| Net Margin | 26.821 |
| Return on Assets | 21.709 |
| Return on Equity | 24.78 |
| Return on Total Capital | 23.759 |
| Return on Invested Capital | 24.78 |
IRMD Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |